ARCHIVES

In Brief: Progress Reported In NCI-FDA Fight Over New Drug Tests, Epidemiology Branch Reorganized

This article is from The Cancer Letter archive.

Vol. 01 No. 50 | December 12, 1975

Download PDF Visit The Full Archive

Related Articles

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

January 21, 2005

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

NCI Changes Deadlines For Two RFAS

July 18, 1997

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000